已收盤 01-09 16:00:00 美东时间
+0.130
+8.84%
Gainers Adlai Nortye (NASDAQ:ANL) stock moved upwards by 44.5% to $2.37 during...
2025-12-29 20:05
Adlai Nortye与ASK Pharm签署AN9025独家许可协议,授权其在 mainland China, Hong Kong, and Macau 开发、生产和商业化。Adlai Nortye将保留全球权利,预计获得高达16亿元人民币的总付款,包括首付款、里程碑付款及销售分成。AN9025是潜在同类最佳的pan-RAS(ON)抑制剂,针对多种肿瘤类型的RAS突变,预计2026年Q1启动I期临床试验。此次合作旨在加速RAS突变癌症患者的治疗开发。
2025-12-29 11:00
Adlai Nortye Ltd. Sponsored ADR ( ($ANL) ) has provided an announcement. Adlai ...
2025-12-03 19:27
Adlai Nortye Ltd. announced that its management team will participate in two upcoming investor conferences: the 8th Annual Evercore Healthcare Conference on December 2, 2025, in Coral Gables, Florida, and the 36th Oppenheimer Annual Healthcare Life Sciences Conference on February 25-26, 2026. The company, focused on innovative cancer therapies, is developing therapies in two key areas: next-generation cancer immunotherapies and RAS-targeting ther...
2025-11-21 13:00
AI, advanced materials and mesh intelligence for aerospaceENGLEWOOD, Colo. and DALLAS and AUSTIN, Texas, Oct. 27, 2025 /PRNewswire/ -- XTI Aerospace, Inc. ("XTI" or the "Company") (NASDAQ:XTIA), advancing scalable
2025-10-27 21:09
Adlai Nortye Ltd. Sponsored ADR ( ($ANL) ) just unveiled an announcement. Adlai...
2025-10-23 05:28
Adlai Nortye Ltd. will present AN4035, a novel CEACAM5-targeting antibody drug conjugate (ADC) with a proprietary pan-RAS(ON) inhibitor payload, at the AACR-NCI-EORTC conference. AN4035 demonstrates strong intracellular retention, potent cytotoxicity in CEACAM5-positive/RAS-addicted cancers, and a favorable toxicology profile. The Company highlights its potential to overcome limitations of existing pan-RAS(ON) inhibitors by targeting tumors speci...
2025-10-22 04:00
10月14日,京东11.11惊喜开放日在京举行。活动现场,京东11.11交出首份成绩单。自10月9日京东11.11全面开启以来,在现货开卖、官方直降等举措下,消...
2025-10-14 16:26
Adlai Nortye Ltd. will present AN4035, a novel CEACAM5-targeting antibody-drug conjugate (ADC) with a pan-RAS(ON) inhibitor payload, at the AACR-NCI-EORTC conference on October 25, 2025. The presentation will discuss the therapeutic potential and design of AN4035 to broaden the treatment window for cancer patients. The company focuses on innovative cancer therapies, including RAS-targeted treatments, and plans to share further details following t...
2025-10-14 03:07
NEW BRITAIN, Conn., Sept. 18, 2025 /PRNewswire/ -- Stanley Black & Decker (NYSE: SWK) today announced that Bill Beck has been appointed President, Tools & Outdoor, effective October 1. Beck ...
2025-09-18 21:32